Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model
Abstract Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility among women of reproductive age, yet the range of effective treatment options remains limited. Our previous study revealed that reduced levels of nicotinamide adenine dinucleotide (NAD+) in ovarian granulosa ce...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2025-01-01
|
| シリーズ: | Journal of Ovarian Research |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s13048-025-01596-4 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|